News Image

Unlocking the Growth Potential of NASDAQ:MEDP.

By Mill Chart

Last update: Oct 18, 2023

In this article we will dive into MEDPACE HOLDINGS INC (NASDAQ:MEDP) as a possible candidate for growth investing. Investors should always do their own research, but we noticed MEDPACE HOLDINGS INC showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Some of the canslim metrics of NASDAQ:MEDP highlighted

  • MEDPACE HOLDINGS INC has shown positive momentum in its earnings per share (EPS) on a quarter-to-quarter (Q2Q) basis, with a 32.19% increase. This reflects the company's successful execution of its business strategies and its commitment to delivering improved financial results.
  • With impressive quarter-to-quarter (Q2Q) revenue growth of 31.22%, MEDPACE HOLDINGS INC showcases its ability to generate increased sales and revenue. This growth indicates the company's strong customer demand and its effective business strategies.
  • The 3-year EPS growth of MEDPACE HOLDINGS INC (34.48%) highlights the company's ability to consistently improve its earnings performance and suggests a positive outlook for future profitability.
  • With a solid Return on Equity (ROE) of 68.65%, MEDPACE HOLDINGS INC exemplifies its ability to generate favorable returns on shareholder investments. This metric demonstrates the company's commitment to maximizing shareholder value.
  • The Relative Strength (RS) of MEDPACE HOLDINGS INC has consistently been strong, with a current 93.08 rating. This indicates the stock's ability to exhibit relative price outperformance and reflects its competitive strength. MEDPACE HOLDINGS INC demonstrates promising potential for sustained price momentum.
  • Maintaining a Debt-to-Equity ratio of 0.14, MEDPACE HOLDINGS INC demonstrates a conservative financial approach. This signifies the company's focus on minimizing debt burdens while preserving a solid equity position.
  • With institutional shareholders at 77.04%, MEDPACE HOLDINGS INC demonstrates a healthy ownership distribution. This reflects a mix of institutional and individual investors, creating a market environment that may foster increased trading activity and price discovery.

Deciphering the Technical Picture of NASDAQ:MEDP

ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.

Overall MEDP gets a technical rating of 3 out of 10. In the last year, MEDP was one of the better performers, although we are getting mixed signals now in both the short and medium term time frames.

  • When comparing the yearly performance of all stocks, we notice that MEDP is one of the better performing stocks in the market, outperforming 93% of all stocks.
  • MEDP is part of the Life Sciences Tools & Services industry. There are 61 other stocks in this industry. MEDP outperforms 86% of them.
  • The short term trend is negative, but the long term trend is still positive. So although the long term is still positive, this may be a trend turning.
  • MEDP is currently trading in the middle of its 52 week range. The S&P500 Index however is trading in the upper part of its 52 week range, so MEDP is lagging the market slightly.

Our latest full technical report of MEDP contains the most current technical analsysis.

How does the complete fundamental picture look for NASDAQ:MEDP?

ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.

MEDP gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 61 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues. MEDP is not overvalued while it is showing excellent growth. This is an interesting combination. This makes MEDP very considerable for growth and quality investing!

Our latest full fundamental report of MEDP contains the most current fundamental analsysis.

More ideas for growth investing can be found on ChartMill in our CANSLIM screen.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

MEDPACE HOLDINGS INC

NASDAQ:MEDP (4/25/2024, 7:04:21 PM)

After market: 389.77 0 (0%)

389.77

-7.79 (-1.96%)

MEDP News

News Image3 days ago - InvestorPlaceMEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024

MEDP stock results show that Medpace Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image3 days ago - BusinessInsiderMEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medpace Hldgs (NASDAQ:MEDP) just reported results for the first quarter of 2024...

News Image4 days ago - Medpace Holdings, Inc.Medpace Holdings, Inc. Reports First Quarter 2024 Results
News Image4 days ago - Market News VideoNoteworthy Monday Option Activity: MEDP, DUK, FUBO
News Imagea month ago - Investor's Business DailyUber Leads Five Stocks Near Buy Points

Five resilient stocks are setting up or flirting with entries.

News Imagea month ago - Medpace Holdings, Inc.Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
News Image2 months ago - Investor's Business DailyThermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months

Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.

News Image2 months ago - Investor's Business DailyAgilent Technologies Stock Getting Closer To Key Technical Benchmark

Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.

News Image2 months ago - Seeking AlphaContract research firms gain after Q4 results (NYSE:IQV)

Shares of contract research organizations IQVIA Holdings (IQV) and Charles River Laboratories (CRL) gain as their Q4 results exceed expectations. Read more here.

MEDP Links
Follow us for more